Curiato successfully completes clinical trial at TGHC

down-arrow

Curiato, Inc. announced today that it has successfully completed its 100-120 patient feasibility pilot at Toronto Grace Health Centre. This research was sponsored by the Centre for Aging and Brain Health Innovation at Baycrest and supported by the University of Waterloo Research Institute for the Aging and Schlegel Villages.

The Company was advised by Toronto Grace Health Centre that the primary endpoints for the pilot have been achieved. These include (i) demonstrating the feasibility of monitoring the interaction of a patient with their bed in a clinical setting, (ii) comparing insights derived from Curiato’s platform against actual nursing assessments, and (iii) compiling a dataset of HAPI risk factors from historical patient records.

You may also like

Recapping an outstanding year for ...
on December 24, 2020

There has been no even-keel or status quo in 2020; companies have either been in trouble or growth ...

Moazam Khan
Data science platform presented at ...
on July 31, 2020

The early-stage health technology company, Curiato, presented its first clinical poster at ...

Moazam Khan
University of Waterloo profile of ...
on February 13, 2020

The University of Waterloo has featured a story about Curiato in its series profiling successful ...

Moazam Khan
Curiato successfully completes ...
on February 8, 2020

Curiato, Inc. announced today that it has successfully completed its 100-120 patient feasibility ...

Moazam Khan